Dashboard
Manage Tickers

GLUEMonte Rosa Therapeutics, Inc.

Nasdaq monterosatx.com


$ 4.19 $ 0.10 (2.44 %)    

Thursday, 06-Jun-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 463.32 $ -0.16 (-0.03 %)
DIA $ 389.27 $ 0.80 (0.21 %)
SPY $ 534.63 $ -0.01 (0 %)
TLT $ 93.23 $ -0.14 (-0.15 %)
GLD $ 219.44 $ 1.61 (0.74 %)
$ 4.19
$ 4.19
$ 4.19 x 192
$ 0.00 x 0
$ 3.98 - $ 4.26
$ 2.44 - $ 8.84
111,549
na
252.05M
$ 2.18
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-14-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-16-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-29-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wedbush-reiterates-outperform-on-monte-rosa-therapeutics-maintains-11-price-target
Wedbush Reiterates Outperform on Monte Ros...
05/22/2024 14:54:30

Wedbush analyst Robert Driscoll reiterates Monte Rosa Therapeutics (NASDAQ:GLUE) with a Outperform and maintains $11 price t...

monte-rosa-therapeutics-will-present-preclinical-data-at-digestive-disease-week-2024-data-showed-that-mrt-6160-mediated-degradation-of-vav1-inhibited-disease-progression-in-a-t-cell-transfer-murine-model-of-colitis
Monte Rosa Therapeutics Will Present Precl...
05/21/2024 11:08:58

VAV1 is a key signaling protein downstream of both the T-and B-cell receptors and its degradation has potential to treat multip...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
05/16/2024 12:06:53

monte-rosa-therapeutics-shares-are-trading-lower-after-the-company-announced-the-pricing-of-a-100-million-public-offering
Monte Rosa Therapeutics shares are trading...
05/16/2024 12:04:18

monte-rosa-therapeutics-reports-pricing-of-100m-public-offering
Monte Rosa Therapeutics Reports Pricing Of...
05/16/2024 11:16:41

The company announced the pricing of an underwritten public offering of 10.638 million shares of its common stock at a public o...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
05/15/2024 20:32:03

monte-rosa-therapeutics-announces-proposed-public-offering-of-common-stock-and-pre-funded-warrants-no-size-or-amount-disclosed
Monte Rosa Therapeutics Announces Proposed...
05/15/2024 20:13:32

Monte Rosa Therapeutics, Inc. ("Monte Rosa") (NASDAQ:GLUE), a clinical-stage biotechnology company developing novel mol...

monte-rosa-therapeutics-expects-its-cash-and-cash-equivalents-of-1978m-to-be-sufficient-to-fund-planned-operations-and-capital-expenditures-into-the-first-half-of-2026
Monte Rosa Therapeutics Expects Its Cash A...
05/09/2024 11:54:26

monte-rosa-therapeutics-q1-2024-gaap-eps-053-beats-059-estimate
Monte Rosa Therapeutics Q1 2024 GAAP EPS $...
05/09/2024 11:53:28

why-westport-fuel-systems-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Westport Fuel Systems Shares Are Tradi...
03/26/2024 17:45:27

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected ...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
03/26/2024 17:31:10

monte-rosa-therapeutics-q4-earnings-insights
Monte Rosa Therapeutics: Q4 Earnings Insights
03/14/2024 13:05:05

monte-rosa-therapeutics-q4-eps-058-misses-033-estimate-cash-balance-of-237m-is-expected-to-provide-cash-runway-into-first-half-of-2026
Monte Rosa Therapeutics Q4 EPS $(0.58) Mis...
03/14/2024 11:12:53

Monte Rosa Therapeutics (NASDAQ:GLUE) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimat...

monte-rosa-therapeutics-announced-mrt-8102-is-expected-to-be-developed-for-inflammatory-diseases-driven-by-interleukin-1-and-the-nlrp3-inflammasome-this-is-the-first-development-candidate-to-be-declared-from-the-companys-nek7-development-program
Monte Rosa Therapeutics Announced MRT-8102...
03/11/2024 11:14:00

correction-wedbush-initiated-coverage-on-monte-rosa-therapeutics-on-thursday-feb-15
CORRECTION: Wedbush initiated coverage on ...
02/16/2024 17:01:35

monte-rosa-therapeutics-ai-and-machine-learning-platform-is-adding-significant-value-creation-in-cancer-research-analyst
Monte Rosa Therapeutics' AI And Machine Le...
02/15/2024 19:05:11

Wedbush initiates coverage on Monte Rosa Therapeutics. With differentiated lead programs and AI-driven QuEEN platform, the comp...

wedbush-initiates-coverage-on-monte-rosa-therapeutics-with-outperform-rating-announces-price-target-of-11
Wedbush Initiates Coverage On Monte Rosa T...
02/15/2024 13:46:43

Wedbush analyst Robert Driscoll initiates coverage on Monte Rosa Therapeutics (NASDAQ:GLUE) with a Outperform rating and ann...

veradigm-aehr-test-systems-saratoga-investment-and-other-big-stocks-moving-lower-on-wednesday
Veradigm, Aehr Test Systems, Saratoga Inve...
01/10/2024 15:27:08

U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. (NA...

monte-rosa-therapeutics-announced-cash-position-expected-to-fund-operations-into-h1-2026
Monte Rosa Therapeutics Announced Cash Pos...
01/08/2024 12:27:15

Monte Rosa Therapeutics (NASDAQ:GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-ba...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
12/14/2023 13:07:41

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION